partner Associated Gastroenterology Medical Group

Gastroenterology

Dr. Dennis S. Riff, MD

Dennis Riff is an expert in the field of Gastroenterology. She went to medical school at Jefferson Medical College. She has 1 awards "Fellow (FACG)". Dennis Riff is a published MD as well. She has 36 publications published. The latest was: A complication of colonoscopic (cecal) polypectomy. She accepts Medicare payments and is listed with Medicare.gov.

Publications

A Phase IIa, Randomized, Double-Blind Study of Remimazolam (CNS 7056) Versus Midazolam for Sedation in Upper Gastrointestinal Endoscopy.
A Phase 3, Randomized, Double-Blind Comparison of Analgesic Efficacy and Tolerability of Q8003 vs Oxycodone or Morphine for Moderate-to-Severe Postoperative Pain Follo...
Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in ...
Analgesic and adverse effects of a fixed-ratio morphine-oxycodone combination (MoxDuo) in the treatment of postoperative pain.
Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: a phase III, placebo-controlled, randomized study.
Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-contr...
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.
Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine/atorvastatin single-pill therapy in treated hypertensive pa...
Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults.
Effect of dutasteride on the risk of prostate cancer.
Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose study.
PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin.
Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, ...
Clinical trial: lansoprazole 15 or 30 mg once daily vs. placebo for treatment of frequent nighttime heartburn in self-treating subjects.
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.
Oral pantoprazole in the form of granules or tablets are pharmacodynamically equivalent in suppressing acid output in patients with gastro-oesophageal reflux disease a...
A randomized, double-blind, one-week study comparing effects of a novel COX-2 inhibitor and naproxen on the gastric mucosa.
Analgesic efficacy of valdecoxib for acute postoperative pain after bunionectomy.
A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease.
A randomized, controlled comparison of ibuprofen at the maximal over-the-counter dose compared with prescription-dose celecoxib on upper gastrointestinal mucosal injury.
Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
A study to determine the nitroglycerin ointment dose and dosing interval that best promote the healing of chronic anal fissures.
A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate...
Efficacy of a motilin receptor agonist (ABT-229) for the treatment of gastro-oesophageal reflux disease.
Efficacy and safety of sodium phosphate tablets compared with PEG solution in colon cleansing: two identically designed, randomized, controlled, parallel group, multic...
Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylor...
Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial.
Rabeprazole is superior to ranitidine in the management of active duodenal ulcer disease: results of a double-blind, randomized North American study.
Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.
The ChemTrak Hp Chek fingerstick whole blood serology test for the detection of Helicobacter pylori infection.
Laparoscopic repair of a colonoscopic perforation.
Triple therapy with lansoprazole, clarithromycin, and amoxicillin for the cure of Helicobacter pylori infection: a short report.
Colonoscopic polypectomy excision of a huge villous adenoma.
A complication of colonoscopic (cecal) polypectomy.

Doctors Specialties

Gastroenterology

Accepted Insurances

Awards

Fellow (FACG)

Education

UC Irvine Medical Center
University of California Irvine
Thomas Jefferson University
Jefferson Medical College

Drug Facts

NPI NUMBER		1922004662
NPPES Provider LastName		RIFF
NPPES Provider FirstName		DENNIS
NPPES Provider ZIPCode		928012811
NPPES Provider State		CA
Specialty Description		Gastroenterology
Total Claim Count		3043.0
Distinct Opioid Count		2.0
Opioid Claim Count		177.0
Percent Opioid Claims		5.82

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1922004662
Last Name Of The Provider	RIFF
First Name Of The Provider	DENNIS
View All

Similar Doctors

	Dr. Bijal P. Surti, MD This Doctor is OpenDoctor Recommended.
	Dr. Andrew Q. Giap, MD This Doctor is OpenDoctor Recommended.